Mittwoch, 04.11.2026, Calendar Week 45, 308. day of the year, 57 days remaining until EoY.

Newsfeed

Bei diesem Bereich handelt es sich um eine mögliche Darstellungsform der Integration von Nachrichtenquellen mit Bezug zu börsennotierten Unternehmen.

Als Präsentationsebene fungiert ein Template, dass an Kurznachrichtenservices angelehnt ist, bei dem sich Nutzer einen schnellen Überblick über aktuelle Nachrichten verschaffen können. Die Detailansichten ermöglichen bei Interesse weitergehende Recherchen.

Dieser Newsfeed ist eine Zusammenstellung aktueller Nachrichten, die aus Direktanbindungen von TopTier NewsWire-Services mit Bezug zu börsennotierten Unternehmen stammen. Dieser Feed hier dient ausschließlich Demonstrationszwecken. Sektoren-spezifische Nachrichten, Public Relations sowie Produktinformationen können über die GICS Portale > Bereich Sektor-Intelligence abgerufen werden.

US44916K1060

Filter zurücksetzen

Do you already know our new terminal view? Click here.

FIGI: BBG00YVTN9J2

HYPR

Hyperfine, Inc.

GICS: Health Care · SECTOR: EQTY · SUB-SECTOR: Medical Devices

NAME

Hyperfine, Inc.

ISIN

US44916K1060

TICKER

HYPR

MIC

XNAS

REUTERS

HYPR.OQ

BLOOMBERG

HYPR US

Do., 15.05.2025 Hyperfine

Newsfeed

Hyperfine, Inc. to Participate in Upcoming Jefferies Global Healthcare Conference | Hyperfine, Inc.

Hyperfine, Inc. to Announce First Quarter 2025 Financial Results on May 13, 2025 | Hyperfine, Inc.

Hyperfine Enrolls Initial Patients in NEURO PMR Study to Evaluate Use of AI-Powered Portable MRI in Neurology Offices | Hyperfine, Inc.

Hyperfine, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results | Hyperfine, Inc.

Hyperfine and NVIDIA Collaborate to Revolutionize Neuroimaging with AI-Powered Innovation | Hyperfine, Inc.

Hyperfine, Inc. to Announce Fourth Quarter and Full Year 2024 Financial Results on March 17, 2025 | Hyperfine, Inc.

Hyperfine Announces $6.0 Million Registered Direct Offering | Hyperfine, Inc.

Hyperfine Reports on Growing Evidence for the Use of Swoop® System Images in Stroke Diagnosis Presented at the 2025 International Stroke Conference | Hyperfine, Inc.

Hyperfine Expands Global Market Reach with New Distribution Partnerships in European and Middle Eastern Markets | Hyperfine, Inc.

Hyperfine Announces Extensive Clinical Study Coverage at RSNA 2024, Showcasing the Body of Evidence Supporting the Use of the Swoop® System Across Different Sites of Care | Hyperfine, Inc.

Hyperfine Announces Strategic Leadership Additions to Drive Growth in Key Business Verticals | Hyperfine, Inc.

Hyperfine Swoop® Portable MR Brain Imaging System Meets New Standards Recently Issued by CMS-Approved Accrediting Body | Hyperfine, Inc.

Hyperfine Announces Ten Abstracts at RSNA, Highlighting the Expanding Utility and Potential of Portable MR Brain Imaging in Diverse Clinical and Research Settings | Hyperfine, Inc.

Hyperfine, Inc. to Participate in Upcoming Investor Conferences | Hyperfine, Inc.

Hyperfine Announces European Launch with CE Approval | Hyperfine, Inc.

Hyperfine Announces Alzheimer’s Research with Promising Swoop® System Data and Advanced Image Quality | Hyperfine, Inc.

Hyperfine, Inc. to Announce Third Quarter 2024 Financial Results on November 12, 2024 | Hyperfine, Inc.

Hyperfine Swoop® Portable MR Imaging® System Utilized in Multicenter SAFE MRI ECMO Study Published in the September 29th Issue of Circulation | Hyperfine, Inc.

Hyperfine Announces Promising Interim Findings on the Value of Portable, Ultra-low-field MR Imaging for Acute Stroke Care | Hyperfine, Inc.

Researchers to Monitor Astronaut Brain Health Using Images Acquired with the Hyperfine, Inc. Swoop® Portable MR Imaging® System | Hyperfine, Inc.

Hyperfine, Inc. to Participate in Upcoming Investor Conferences | Hyperfine, Inc.

Hyperfine, Inc. Reports First Quarter 2024 Financial Results | Hyperfine, Inc.

Thinking about buying stock in Applied UV, Tilray Brands, Hyperfine, Smart Sand, or Nordic American Tankers? | Hyperfine, Inc.